(Press-News.org) In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment.
This study analyzed utDNA from patients in the SWOG S1605 trial, who were treated with atezolizumab, an immunotherapy drug. Researchers used the UroAmp test to examine urine samples from 89 patients at the start of treatment and from 77 patients three months later. The goal was to see if utDNA could help identify which bladder cancer patients are most likely to respond to immunotherapy.
“This approach could help improve patient care by guiding more effective treatments and supporting more personalized plans,” said Robert Svatek, MD, MSCI, professor and chair of urology at the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio). “It means we may be able to tailor therapy sooner, reduce unnecessary delays and help patients avoid major surgery without compromising the quality of their care.”
A nationally recognized urologic oncologist with the Mays Cancer Center at UT Health San Antonio, Svatek is the leading expert in bladder cancer and a member of SWOG, also known as Southwest Oncology Group. SWOG is part of the National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN) and one of the five leading cancer clinical trial groups in the United States.
The SWOG S1605 study was a phase 2 clinical trial testing atezolizumab in patients with high-risk bladder cancer that didn’t respond to BCG (Bacillus Calmette-Guérin) treatment, the main immunotherapy to treat early-stage bladder cancer.
Samples were collected from participants before treatment and again three months later. Researchers used the UroAmp assay, a non-invasive urine test that detects bladder cancer–related mutations, to analyze utDNA and generate a genomic profile for each patient.
They found that utDNA levels were linked to how well patients responded after six months and how long they stayed cancer-free over 18 months. Patients with positive utDNA results were less likely to respond and more likely to have their cancer return.
According to the American Cancer Society, bladder cancer is the sixth most common cancer in the United States, with more than 83,000 new cases diagnosed annually. Of these cases, approximately 75% are non–muscle invasive, meaning the cancer has not yet invaded the bladder muscle.
Patients who don’t respond to immunotherapy may face the difficult decision of either continuing therapies that spare the bladder but carry high risks of recurrence or undergo major surgery that removes the bladder and profoundly impacts one’s quality of life.
This study offers new hope for patients with high-risk bladder cancer by showing that a urine-based DNA test can help predict who is more likely to benefit from immunotherapy. By identifying treatment response early, this approach could guide more personalized, bladder-preserving care and reduce the need for major surgery.
To learn more about bladder cancer care and cancer programs at the Mays Cancer Center at UT Health San Antonio, visit MaysCancerCenter.org.
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is one of the country’s leading health science and research universities. With missions of teaching, research and patient care, its schools of medicine, nursing, dentistry, health professions, graduate biomedical sciences and public health have graduated more than 45,000 alumni who are leading change, advancing their fields and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit UTHealthSA.org.
Stay connected with UT Health San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
The Mays Cancer Center at UT Health San Antonio is one of only four National Cancer Institute-designated Cancer Centers in Texas. The Mays Cancer Center provides leading-edge cancer care, propels innovative cancer research and educates the next generation of leaders to end cancer in South Texas. In 2017, Mays Cancer Center became one of a select few centers in the nation to partner with MD Anderson Cancer Center, expanding access to cancer treatments that are among the most advanced in the nation–close to home. To learn more, visit https://cancer.uthscsa.edu.
Stay connected with the Mays Cancer Center on Facebook, Twitter, LinkedIn, Instagram and YouTube.
END
New urine-based tumor DNA test may help personalize bladder cancer treatment
2025-06-27
ELSE PRESS RELEASES FROM THIS DATE:
How a faulty transport protein in the brain can trigger severe epilepsy
2025-06-27
Citrate is essential for the metabolism and development of neurons. A membrane transport protein called SLC13A5 plays a central role in this process and has previously been linked to a particularly severe form of epileptic encephalopathy. Building on data from the recently completed RESOLUTE and REsolution flagship projects, scientists at CeMM have comprehensively studied the function and structure of the membrane transporter SLC13A5, experimentally investigating 38 mutant variants. Their findings, published in Science Advances (DOI 10.1126/sciadv.adx3011) shed new light on the mechanisms of this disease and lay the ...
Study reveals uneven land sinking across New Orleans, raising flood-risk concerns
2025-06-27
Parts of New Orleans and its surrounding wetlands are gradually sinking, and while most of the city remains stable, a new study from Tulane University researchers suggests that sections of the region’s $15 billion post-Katrina flood protection system may need regular upgrades to outpace long-term land subsidence.
The study, published in Science Advances, used satellite radar data to track subtle shifts in ground elevation across Greater New Orleans between 2002 and 2020. The study found that some neighborhoods, wetlands and even sections of floodwalls are sinking by more than an inch per year — with some ...
Researchers uncover novel mechanism for regulating ribosome biogenesis during brain development
2025-06-27
Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, multi-step process by which they are made.
During brain development, neural stem cell proliferation relies on active ribosome biogenesis to meet high protein demand. This process involves the concerted action of numerous ribosomal RNA processing factors and assembly proteins. Studies have shown that precise regulation of ribosome biogenesis is essential for normal brain development and tumor prevention.
N6-Methyladenosine ...
RNA codon expansion via programmable pseudouridine editing and decoding
2025-06-27
Peking University, June 27, 2025: To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian cells, researchers from Peking University led by Chen Peng from College of Chemistry and Molecular Engineering and Yi Chengqi from School of Life Sciences have developed a novel codon expansion strategy that enables precise incorporation of noncanonical amino acids (ncAAs) without perturbing natural genetic codes. This innovative approach utilizes post-transcriptionally modified RNA codons—distinct from all 64 standard genetic codons—within targeted transcripts to encode ncAAs ...
Post-diagnosis emergency department presentation and demographic factors in malignant skin cancers
2025-06-27
Background and objectives
Emergency department (ED) presentations are associated with higher cancer mortality. This study aimed to investigate the prevalence, frequency, and risk factors in Australian patients diagnosed with malignant skin cancers.
Methods
This data-linkage cohort study examined adult patients presenting to the ED at the Royal Melbourne and Western Health hospitals within 12 months of a malignant skin cancer diagnosis. Multivariable logistic and Poisson regressions were used to analyze factors influencing the prevalence and frequency of ED presentations.
Results
A total ...
A new genetic tuner for embryo development
2025-06-27
The research was led by Dr Irène Amblard and Dr Vicki Metzis from the Development and Transcriptional Control group, in collaboration with LMS facilities and the Chromatin and Development and Computational Regulatory Genomics groups.
All cells contain the same DNA but must turn specific genes ‘on’ and ‘off’ – a process known as gene expression – to create different body parts. The cells in your eyes and arms harbour the same genes but ‘express’ them differently to become each body part. The work focused on the gene Cdx2. The duration of Cdx2 expression helps to determine where and when a cell produces ...
Insurance churn and the COVID-19 pandemic
2025-06-27
About The Study: In this study, the Families First Coronavirus Response Act was associated with a significantly decreased risk of losing health insurance for individuals enrolled in the Medicaid program.
Corresponding Author: To contact the corresponding author, Sarah P. Shubeck, MD, MS, email shubeck@bsd.uchicago.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2025.1467)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, ...
Postpartum Medicaid use in birthing parents and access to financed care
2025-06-27
About The Study: The results of this study suggest that extending Medicaid coverage for 12 months postpartum was associated with expanded opportunities for greater access to Medicaid-financed medical and behavioral health care. Both prevention and ongoing treatment of chronic conditions may help mitigate key adverse outcomes. The findings may help policymakers and public health officials understand how extended coverage affects access to Medicaid-financed care.
Corresponding Author: To contact the corresponding author, Jonas J. Swartz, MD, MPH, email jonas.swartz@duke.edu.
To ...
Manufacturing chemicals via orthogonal strategy, making full use of waste plastic resources in real life
2025-06-27
Peking University, June 27, 2025: Addressing the challenge of waste plastics treatments, the scientific community has been pursuing innovative solutions. Recently, Peking University researchers led by Ma Ding from College of Chemistry and Molecular Engineering, in collaboration with Xu Shutao from Dalian Institute of Chemical Physics, Chinese Academy of Sciences, uncovered how complex plastic mixtures can be utilized based on the differences in the physical and chemical properties of the components with the aids of NMR technique and catalytic approaches. This work provides a new treatment ...
Study overturns long-held belief about shape of fish schools
2025-06-27
For 50 years, scientists believed that schools of fish would save the most energy by swimming in flat diamond formations. Recently, a team of researchers at Princeton and Harvard ran an experiment to check this assumption.
It turns out that, contrary to what models predicted, fish don’t swim in diamonds. They swim in a dynamic pattern that the researchers call a ladder, where they’re staggered in three dimensions like an echelon of fighter jets.
The research team, led by Radhika Nagpal, professor of robotics at Princeton, adapted computer vision software originally developed to track individual animal movements to collect the first 3D data ...